Frontotemporal Lobar Degeneration

Frontotemporal lobar degeneration or frontotemporal dementia refers to a group of uncommon disorders that occur as a result of progressive nerve cell loss in the frontal and temporal lobes of the brain. Here is the latest research.

September 23, 2020
Review

Tubulin modifying enzymes as target for the treatment of tau-related diseases

Pharmacology & Therapeutics
Krzysztof RogowskiSiem Van Der Laan
September 25, 2020

Modulating TRADD to restore cellular homeostasis and inhibit apoptosis

Nature
Daichao XuJunying Yuan
September 20, 2020
Review

Potential human transmission of amyloid β pathology: surveillance and risks

Lancet Neurology
Elsa LauwersBart De Strooper
September 25, 2020
Review
Open Access

Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology

Cells
Noemi Esteras, Andrey Y Abramov
September 23, 2020

Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations

Parkinsonism & Related Disorders
Fábio CarneiroIsabelle Le Ber
September 24, 2020

Inside minds, beneath diseases: social cognition in amyotrophic lateral sclerosis-frontotemporal spectrum disorder

Journal of Neurology, Neurosurgery, and Psychiatry
Patricia LilloLeonardo Cruz de Souza
September 23, 2020
Case Report

Progressive phonagnosia in a telephone operator carrying a C9orf72 expansion

Cortex; a Journal Devoted to the Study of the Nervous System and Behavior
Mira DidicOlivier Felician
September 24, 2020
Review

Proteasome Subunits Involved in Neurodegenerative Diseases

Archives of Medical Research
Iván Fernández-Cruz, Enrique Reynaud
September 18, 2020
Case Report

Transient epileptic amnesia can inaugurate the behavioural variant of frontotemporal dementia

Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society
Benjamin CretinFrederic Blanc
September 23, 2020

Methionine-Mediated Protein Phosphatase 2A Catalytic Subunit (PP2Ac) Methylation Ameliorates the Tauopathy Induced by Manganese in Cell and Animal Models

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Bin WuCailing Lu
September 18, 2020

Diabetic Theory in Anti-Alzheimer's Drug Research and Development. Part 2: Therapeutic Potential of cAMP-Specific Phosphodiesterase Inhibitors

Current Medicinal Chemistry
Agnieszka JankowskaGrażyna Chłoń-Rzepa
September 20, 2020
Open Access

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes

Annals of Clinical and Translational Neurology
Yu GuoAlzheimer's Disease Neuroimaging Initiative
September 24, 2020
Comment / Editorial

Oxytocin and mimicry enhance brain activity during social cognition in frontotemporal dementia

Neurology
Hitoshi Shinotoh
September 18, 2020
Review
Open Access

Activate or Inhibit? Implications of Autophagy Modulation as a Therapeutic Strategy for Alzheimer's Disease

International Journal of Molecular Sciences
Sharmeelavathi KrishnanPrashant Bharadwaj
September 20, 2020

Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases

Neuropathology and Applied Neurobiology
Evelien Van SchoorDietmar Rudolf Thal
September 23, 2020

The role of the cellular prion protein in the uptake and toxic signaling of pathological neurodegenerative aggregates

Progress in Molecular Biology and Translational Science
Carlo Scialò, Giuseppe Legname
September 23, 2020

The utility of bank voles for studying prion disease

Progress in Molecular Biology and Translational Science
Hamza ArshadJoel C Watts

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/frontotemporal-lobar-degeneration/eee21060-95aa-4d1d-8ae1-d117899ee65f